Dr. David Pisetsky of Duke University Medical Center discusses immune response to DNA and its role in stimulating lupus.
Dr. Emily Von Scheven, Director of Pediatric Rheumatology at the University of California San Francisco Medical Center, discusses the issues surrounding bone health in children with lupus and other health issues associated with treatment of lupus.
Dr. Isenberg discusses several of the new agents under evaluation for lupus and looks to ways lupus treatment will change with evolving technology and new scientific findings.
Dr. Ram Raj Singh of the University of California Los Angeles discusses findings from studies that may provide clues into the possible causes of lupus skin disease.
Dr. John Harley, Director of Rheumatology at the Cincinnati Children's Hospital, discusses the genes investigators believe may play a role in the underlying cause of lupus.
Dr. Meenakshi Jolly of the Rush University Medical Center shares observations from studies conducted to learn how to improve the quality of life for people with lupus.
Dr. Lakshmi Nandini Moorthy, chief of pediatric rheumatology at the Robert Wood Johnson Medical School in New Brunswick, discusses a tool to measure the health related quality of life (HRQOL) among children with lupus.
Dr. Michael Ward, an investigator with the intramural research program for the National Institute of Arthritis and Musculoskeletal and Skin Diseases, reviews how biomarkers are used to diagnose lupus and monitor disease activity.